Trinity Biotech (TRIB) EBT (2009 - 2024)

Trinity Biotech has disclosed EBT across 16 years of filings, most recently posting -$15.8 million for Q4 2024.

• In Q4 2024, EBT fell 186.96% year-over-year to -$15.8 million; the TTM figure through Dec 2024 stood at -$30.7 million (up 16.8% YoY), while the FY2025 annual figure was -$37.2 million, down 20.98% from the prior year.
• EBT came in at -$15.8 million for Q4 2024 at Trinity Biotech, down from -$4.8 million in the prior quarter.
• In the past five years, EBT ranged from a high of $7.9 million in Q3 2020 to a low of -$18.6 million in Q2 2023.
• Average EBT over 5 years is -$4.8 million, with a median of -$5.1 million recorded in 2023.
• Year-over-year, EBT soared 3631.28% in 2020 and sank 7829.69% in 2022.
• Over 5 years, EBT stood at $7.8 million in 2020, then sank by 130.96% to -$2.4 million in 2021, then tumbled by 329.53% to -$10.4 million in 2022, then soared by 47.21% to -$5.5 million in 2023, then slumped by 186.96% to -$15.8 million in 2024.
• Per Business Quant data, the three most recent EBT figures were -$15.8 million in Q4 2024, -$4.8 million in Q3 2024, and -$6.9 million in Q2 2024.